(Q45914110)

17 December 2017

title

Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. (English)

1 reference

17 December 2017

main subject

hepatocellular carcinoma

1 reference

Quanrongzi Wang

1

1 reference

17 December 2017

Tongfu Yu

2

1 reference

17 December 2017

Yifeng Yuan

3

1 reference

17 December 2017

Haiwen Zhuang

4

1 reference

17 December 2017

Zhaojing Wang

5

1 reference

17 December 2017

Xisheng Liu

6

1 reference

17 December 2017

Min Feng

7

1 reference

17 December 2017

publication date

25 July 2012

1 reference

17 December 2017

Journal of Surgical Oncology

published in

1 reference

17 December 2017

volume

107

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

422-427

1 reference

17 December 2017

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

cites work

1 reference

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

21 January 2018

1 reference

Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.

21 January 2018

1 reference

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

21 January 2018

1 reference

Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes

21 January 2018

1 reference

Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg

21 January 2018

1 reference

Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells

21 January 2018

1 reference

Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2

21 January 2018

1 reference

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma

21 January 2018

1 reference

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

21 January 2018

1 reference

The role of JNK in the development of hepatocellular carcinoma

21 January 2018

1 reference

B-Raf-mediated signaling pathway regulates T cell development

21 January 2018

1 reference

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23227

1 reference

17 December 2017

1 reference

17 December 2017